18.04.2024 14:12 | SSON, WEIR, TRX | UK shareholder meetings calendar - next 7 days | Alliance |
05.04.2024 15:52 | TRX | Holding(s) in Company | RNS |
19.03.2024 14:24 | TRX | Tissue Regenix annual loss narrows sharply as revenue jumps | Alliance |
19.03.2024 07:00 | TRX | Final results for the year ended 31 December 2023 | RNS |
12.03.2024 14:29 | ZTF, TRST, TRX | UK earnings, trading statements calendar - next 7 days | Alliance |
01.03.2024 07:00 | TRX | Notice of Results | RNS |
06.02.2024 10:42 | TRX | IN BRIEF: Tissue Regenix ships first allograft products order | Alliance |
29.01.2024 15:02 | TRX | Holding(s) in Company | RNS |
25.01.2024 20:21 | KETL, PGH, EMR | TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up | Alliance |
25.01.2024 07:00 | TRX | Trading update for 2023 | RNS |
23.01.2024 17:24 | TRX | 2023 LTIP Grant | RNS |
22.11.2023 16:36 | TRX | Holding(s) in Company | RNS |
30.10.2023 14:31 | TRX, PPP, RBGP | TRADING UPDATES: Solid State expects higher annual revenue | Alliance |
30.10.2023 07:00 | TRX | HPRA approval & distribution agreement in Spain | RNS |
15.09.2023 16:30 | TRX | Director/PDMR Shareholding | RNS |
05.09.2023 11:50 | TRX | Tissue Regenix loss narrows on higher revenue; launches BioRinse | Alliance |
05.09.2023 07:01 | TRX | New sports medicine product launch | RNS |
05.09.2023 07:00 | TRX | Interim results | RNS |
31.08.2023 13:45 | TRX | Exercise of Options and Total Voting Rights | RNS |
29.08.2023 15:45 | TRX, STVG, SRC | UK earnings, trading statements calendar - next 7 days | Alliance |
21.08.2023 07:00 | TRX | Notice of interim results | RNS |
17.07.2023 15:49 | AMOI, CMRS, THAL | TRADING UPDATES: Beacon sees delays; Churchill China trades in line | Alliance |
17.07.2023 07:00 | TRX | Half-Year Trading Update | RNS |
10.07.2023 11:37 | TRX | Tissue Regenix signs exclusive distribution deal with Joint Operations | Alliance |
10.07.2023 07:00 | TRX | Distribution agreement for OrthoPure® XT in the UK | RNS |
25.05.2023 10:45 | TRX | IN BRIEF: Tissue Regenix signs multi-year distribution contract | Alliance |
25.05.2023 07:00 | TRX | Distribution agreement with Australian Allografts | RNS |
22.05.2023 12:25 | TRX, SUN | IN BRIEF: Surgical Innovations says Glenn becomes chair later this year | Alliance |
09.05.2023 12:00 | TRX | Holding(s) in Company | RNS |
27.04.2023 12:35 | TRX | Result of AGM, Share Reorganisation &TVR | RNS |
18.04.2023 18:49 | HMI, TRX | TRADING UPDATES: FireAngel signs two delivery and production deals | Alliance |
18.04.2023 07:00 | TRX | Proposed Share Reorganisation Timetable | RNS |
05.04.2023 14:55 | TRX | Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative | EQS |
05.04.2023 07:00 | TRX | CEO and CFO Share Purchases | RNS |
30.03.2023 07:00 | TRX | Holding(s) in Company | RNS |
21.03.2023 12:37 | TRX | IN BRIEF: Tissue Regenix reports narrowed loss and higher revenue | Alliance |
21.03.2023 07:00 | TRX | Final results for the year ended 31 December 2022 | RNS |
14.03.2023 15:49 | ZTF, YOU, TRST | UK earnings, trading statements calendar - next 7 days | Alliance |
06.03.2023 07:00 | TRX | Notice of results and Investor presentation | RNS |
31.01.2023 21:38 | TRX, PPS, TEM | TRADING UPDATES: LifeSafe Holdings, Tissue Regenix see revenue growth | Alliance |
31.01.2023 07:01 | TRX | Trading update for 2022 | RNS |
31.01.2023 07:00 | TRX | Change of Adviser | RNS |
18.01.2023 12:41 | TRX | Tissue Regenix signs Chinese distribution agreement for OrthoPure XT | Alliance |
18.01.2023 10:06 | TRX | Holding(s) in Company | RNS |
18.01.2023 07:00 | TRX | Chinese distribution agreement for OrthoPure® XT | RNS |
07.12.2022 15:48 | TRX | IN BRIEF: Tissue Regenix launches allograft to aid weakened tissue
| Alliance |
07.12.2022 07:00 | TRX | Product launch in dCELL® division | RNS |
22.11.2022 14:22 | TRX | Tissue Regenix secures non-human ACL graft distributer deal in Germany | Alliance |
22.11.2022 07:00 | TRX | Distribution agreement - OrthoPure® XT in Germany | RNS |
14.11.2022 18:05 | TRX | Holding(s) in Company | RNS |
07.11.2022 14:35 | TRX | Holding(s) in Company | RNS |
29.09.2022 10:13 | TRX | Director/PDMR Shareholding | RNS |
27.09.2022 07:15 | TRX | Hardman & Co Research on Tissue Regenix (TRX): Operating leverage | EQS |
07.09.2022 11:21 | KIST, ARA, TRX | EARNINGS UPDATES: Maiden Union Jack Oil profit; Kistos revenue jumps | Alliance |
07.09.2022 07:00 | TRX | Half-year Report | RNS |
31.08.2022 15:57 | SMWH, TRX, SOM | UK earnings, trading statements calendar - next 7 days | Alliance |
22.08.2022 15:31 | TRX | Holding(s) in Company | RNS |
18.08.2022 17:36 | TRX | Holding(s) in Company | RNS |
18.08.2022 14:10 | TRX | Holding(s) in Company | RNS |
11.08.2022 16:30 | TRX | Hardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct | EQS |
11.08.2022 12:46 | TRX | Holding(s) in Company | RNS |
11.08.2022 12:17 | TRX | Holding(s) in Company | RNS |
11.08.2022 07:00 | TRX | Confirmation of Interim Results | RNS |
05.08.2022 15:19 | TRX | Holding(s) in Company | RNS |
01.08.2022 15:14 | TRX | Holding(s) in Company | RNS |
19.07.2022 14:30 | TRX | Hardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential | EQS |
19.07.2022 07:00 | TRX | Half Year Trading Update and Notice of Results | RNS |
18.07.2022 14:42 | DIVI, TRX | Holding(s) in Company | RNS |
18.07.2022 13:33 | TRX | Holding(s) in Company | RNS |
15.07.2022 17:29 | TRX | Holding(s) in Company | RNS |
27.06.2022 18:04 | TRX | Holding(s) in Company | RNS |
27.06.2022 12:58 | TRX | Holding(s) in Company | RNS |
16.06.2022 13:27 | TRX | Exercise of Options and Total Voting Rights | RNS |
28.04.2022 07:00 | TRX | OrthoPure®XT clinical results presentation | Reach |
26.04.2022 16:19 | TRX | Result of AGM | RNS |